Business Wire

The Commission on Elections in the Philippines Selects Gemalto’s Biometrics Solution to Ensure Secure and Rapid Voter Authentication

Share

Electoral commissions have the delicate task of maintaining reliable and correct electoral registers as part of the execution of the election. To help ensure secure and accurate voter verification before issuing ballot slips, the Commission on Elections (COMELEC) in the Philippines has appointed Gemalto, a Thales company, and Nextix as technology partners to develop, deploy and support the Biometric Voter Verification System for the 2019 Philippines National and Local Election. The aim is to automate the verification of voters through the use of their biometrics information.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190512005010/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Secure Voter Authentication (Photo: Thales)

Addressing this need, Gemalto will provide over 30,000 biometric tablets to enable rapid identification and authentication of voters in the designated precincts across the Philippines. With the tablets that feature Gemalto’s Voter Verification System, authorities will be able to reduce fraud by verifying voters’ identity via their fingerprints. This will also help cut waiting times for the voters and authorities tremendously.

COMELEC will use the Gemalto solution to verify the identity of voters. This was put to a test at the first time during the mock elections held on 19th Jan 2019, in preparation for the actual polls in May 2019. Instead of manually checking the COMELEC’s voters list, members of the Board of Election Inspectors used the Voter Registration Verification Tablet, a system that removes the need for voters to present their identification card. Thanks to the tablet the electoral board will identify the voter's with his fingerprint to determine if the voter is registered and whether the individual belongs to the certain precinct. If the individual is a registered voter, the tablet will validate the registration and a he will receive the necessary ballot.

Fingerprints serve as a key to avoid duplication. The aim is to ensure that citizens are not able to use several identities to vote multiple times. The Voter Verification System implements a quality control to verify that the data has been captured and verified correctly. Authorities are also able to track voting activity and participation rate via logs and audit reports. These steps will ensure the best possible level of security for elections to take place.

“Secure, reliable and comprehensive enrollment and ID verification are the foundations of citizen registration, voting processes and border controls,” said Dir. James Jimenez. “With Gemalto’s Voter Verification System, we are able to streamline not only the verification but moving ahead, our registration processes bring greater convenience to citizens, guaranteeing the quality and confidentiality of data captured. We are excited to deploy this solution – a first for the Philippines government.”

“In today’s environment, authorities face numerous challenges. Biometrics serve as the primary data that establishes an individual's identity is accurately collected and verified. We are proud that the Commission on Elections (COMELEC) chose Gemalto biometric solution to verify the identity of voters. It is an honor to help COMELEC transform the agility and efficiency of the voters’ verification and registration processes.” Tan Teck Lee, Asia President, Identity & Biometric Solutions, Thales.

Note to editors

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. Gemalto’s technologies and services authenticate people, transactions and objects, encrypt data and create value for software – enabling businesses and governments to deliver secure digital services for billions of individuals and things.

About Thales

The people we all rely on to make the world go round – they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer. Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary high technology solutions. Solutions that make tomorrow possible, today. From the bottom of the oceans to the depth of space and cyberspace, we help our customers think smarter and act faster - mastering ever greater complexity and every decisive moment along the way. With 80,000 employees in 68 countries, Thales reported sales of €19 billion in 2018.

PLEASE VISIT

Thales Group
Digital Security
Download HD photos

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS
Thales, Media Relations
Security
Constance Arnoux
+33 (0)6 44 12 16 35
constance.arnoux@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases10.12.2025 08:01:00 EET | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with the Brazilian company Libbs Farmacêutica! Through this strategic partnership, Libbs Farmacêutica will gain exclusive rights to commercialize a cutting-edge biosimilar for autoimmune diseases in the rapidly growing Brazilian market. Polpharma Biologics retains full responsibility for the development and manufacturing of the biosimilar. Libbs Farmacêutica will hold an exclusive license for the commercialization, marketing and distribution of the biosimilar in Brazil. This collaboration opens up exciting new opportunities and demonstrates the shared commitment of both companies to delivering innovative and accessible therapies to patients. “Entering the Brazilian market with a biosimilar is a significant step for Polpharma Biologics and reflects our ongoing mission to expand access to high-qual

NayaPay Launches Global QR Payments for Pakistanis via Alipay+10.12.2025 06:00:00 EET | Press release

NayaPay, one of Pakistan’s fastest growing fintech platforms, has launched global QR payments in collaboration with Alipay+, Ant International’s global wallet gateway. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209591389/en/ The partnership enables millions of NayaPay users to scan-and-pay at Alipay+ merchants initially across more than 50 countries, connecting Pakistani consumers to an extensive global ecosystem spanning retail, dining, transport, healthcare, entertainment and more. With this innovative feature, paying abroad just got faster and more affordable. With NayaPay, Pakistanis can now scan and pay securely worldwide with lower costs, less friction, and a seamless checkout experience wherever they go. Alipay+ connects 40 international mobile payment partners to more than 150 million merchants globally. The launch reinforces NayaPay’s commitment to delivering world-class payment experiences to Pakistani consu

Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator10.12.2025 04:50:00 EET | Press release

Biocytogen (Beijing) Pharmaceutical Technology Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This follows the Company’s listing on the Hong Kong Stock Exchange in September 2022 and marks a significant milestone in establishing Biocytogen as the first “H+A” dual-listed global drug innovator, reinforcing its mission to become the global headstream of new drugs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209977992/en/ The Company’s IPO price was set at 26.68 RMB per share, with an opening price of 58 RMB, representing a 117% increase over the offering price. Based on the opening price, Biocytogen’s market capitalization exceeds 25.9 billion RMB. Biocytogen’s proprietary RenMice® platforms (RenMab™, RenLite®, RenNano®, RenTCR-mimic™) enable the discovery of fully hum

Argo Infrastructure Partners Increases Ownership and Capital Commitment to TierPoint10.12.2025 00:00:00 EET | Press release

Argo Infrastructure Partners, LP (“Argo”), an established mid-market asset manager of essential infrastructure assets in North America, today announced it has acquired on behalf of its managed funds the equity interests of the majority of minority shareholders in TierPoint. The transaction reflects Argo’s continued conviction in TierPoint’s strategy and growth potential during a period of accelerating demand for TierPoint’s enterprise-class data center services. Since Argo’s initial investment in 2020, $3 billion of capital has been raised to fund growth and reduce TierPoint’s cost of capital by terming out debt facilities. The investment capital has advanced TierPoint’s market position as a data center services provider to enterprises, government organizations, hyperscalers and other consumers of state-of-the-art digital infrastructure. With these investments, Argo has supported the national expansion of TierPoint’s data center platform, and its efforts to meet and exceed customers’ r

Venture Global Announces Closing of $3,000,000,000 Senior Secured Notes by Venture Global Plaquemines LNG, LLC9.12.2025 23:30:00 EET | Press release

Venture Global, Inc. (“Venture Global”, NYSE: VG) announced today that its subsidiary, Venture Global Plaquemines LNG, LLC (“VGPL”) has closed an offering of $3,000,000,000 aggregate principal amount of senior secured notes, which has been issued in two series: (i) a series of 6.125% senior secured notes due 2030 in an aggregate principal amount of $1,750,000,000 (the “2030 Notes”) and (ii) a series of 6.500% senior secured notes due 2034 in an aggregate principal amount of $1,250,000,000 (the “2034 Notes” and, together with the 2030 Notes, the “Notes”). The 2030 Notes will mature on December 15, 2030, and the 2034 Notes will mature on June 15, 2034. Venture Global had previously announced the issuance of $2,500,000,000 of senior secured notes by VGPL on April 21, 2025, and $4,000,000,000 of senior secured notes by VGPL on July 3, 2025 (collectively, the “Existing Notes”), bringing the combined aggregate amount of senior secured notes issued by VGPL to $9,500,000,000 since the project

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye